Capital Stock | Note 6. Capital Stock Authorized Capital Authorized capital stock consists of 200,000,000 shares of Common Stock with par value of $ 0.01 per common share (2023 - 200,000,000 shares of Common Stock with par value $ 0.01 per common share). During the year-ended June 30, 2024, the Company issued 6,379,754 shares for net proceeds of $ 1,923,120 through its at-the-market offering and issued 3,142,803 shares for the payment of accrued interest (Note 7) with a fair value of $ 1,117,837 . The Company also issued 709,500 shares related to awards made under its equity compensation plans. During the year-ended June 30, 2023, the Company issued 6,996,054 shares for net proceeds of $ 2,219,796 through its at-the market offering and issued 799,613 shares for payment of interest accrued and owing (Note 5 and Note 7) with a fair value of $ 320,826 . The Company also issued 425,500 shares related to awards under its equity compensation plans. Stock Options, Restricted Stock Units and Stock Based Compensation Paramount’s 2015 and 2016 Stock Incentive and Compensation Plans, which are stockholder-approved, permits the grant of stock options, restricted stock units and stock to its employees and directors for up to 5.5 million shares of common stock. Total stock-based compensation for the years-ended June 30, 2024 and 2023 were $ 331,095 and $ 349,992 respectively. Total stock-based compensation for the year-ended June 30, 2024 consists of the aggregate of stock-based compensation recorded for outstanding stock-option awards $ 4,899 (2023 - $ 24,467 ), restricted stock unit awards $ 292,827 (2023 - $ 303,025 ) and restricted stock grant awards $ 33,370 (2023 - $ 22,500 ). Restricted Stock Grants During the year-ended June 30, 2024, the Company granted and issued 94,000 shares (2023 - 75,000 ) of Common stock under its equity compensation plan with a fair value of $ 33,370 (2023 - $ 22,500 ). Stock Options and Stock Based Compensation Stock option awards are generally granted with an exercise price equal to the market price of Paramount’s stock at the date of grant and have contractual lives of 5 years . To better align the interests of its key executives, employee and directors with those of its shareholders a significant portion of those share option awards will vest contingent upon meeting certain stock price appreciation performance goals and other performance conditions. Option and share awards provide for accelerated vesting if there is a change in control (as defined in the employee equity compensation plan). For the year-ended June 30, 2024 and 2023, the Company granted nil and 50,000 stock options to employees, directors and consultants, respectively. For the year-ended June 30, 2024, share-based compensation expense relating to service conditions options and performance conditions options were $ nil and $ 4,899 , respectively (2023 - $ 12,021 and $ 12,446 ). The fair value for these options was calculated using the Black-Scholes option valuations method. The weighted average assumptions used for the fiscal years ending June 30, 2024 and 2023 were as follows: Twelve Months Ended June 30, 2024 Twelve Months Ended June 30, 2023 Weighted average risk-free interest rate N/A 2.79 % Weighted-average volatility N/A 58 % Expected dividends N/A 0 Weighted average expected term (years) N/A 5 Weighted average fair value N/A $ 0.19 A summary of option activity under the Stock Incentive and Compensation Plan as of June 30, 2024 and 2023, and changes during the years ended June 30, 2024 and 2023 are presented below. Options Options Weighted Price Weighted- Aggregate Value Outstanding at June 30, 2022 1,808,995 $ 1.14 2.42 $ — Granted 50,000 0.60 4.00 — Exercised — — — — Forfeited or expired ( 453,995 ) 1.37 — — Outstanding at June 30, 2023 1,405,000 $ 1.05 2.06 $ — Granted — — — — Exercised — — — — Forfeited or expired — — — — Outstanding at June 30, 2024 1,405,000 $ 1.05 1.06 $ — Exercisable at June 30, 2024 946,664 $ 1.05 1.13 $ — A summary of the status of Paramount’s non-vested options as of June 30, 2024 and 2023 and changes during the years ended June 30, 2024 and 2023 are presented below. Non-vested Options Options Weighted- Grant- Non-vested at June 30, 2022 657,333 $ 0.55 Granted 50,000 0.19 Vested ( 95,002 ) 0.41 Forfeited or expired ( 153,995 ) 0.82 Non-vested at June 30, 2023 458,336 $ 0.47 Granted — — Vested — — Forfeited or expired — — Non-vested at June 30, 2024 458,336 $ 0.47 As of June 30, 2024 and 2023, there was $ 3,275 and $ 8,174 respectively of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the employee share option plan. This expense is expected to be recognized over a weighted-average period of 0.85 years. The total fair value of stock options vested during the years ended June 30, 2024 and 2023, was nil and $ 26,552 respectively. Restricted Stock Units ("RSUs") RSUs are awards for service and performance which upon vesting and settlement entitle the recipient to receive one common share of the Company's Common Stock for no additional consideration, for each RSU held. During the year-ended June 30, 2024, the Company granted 1,360,000 RSUs (2023 - 630,000 ) During the year-ended June 30, 2024, share-based compensation expenses related to service condition RSUs and performance condition RSUs was $ 191,136 and $ 101,691 , respectively (2023 - $ 161,756 and $ 141,269 ) A summary of RSUs activity is summarized as follows: Restricted Share Unit Activity Outstanding RSUs Weighted average grant date fair value Outstanding at June 30, 2022 701,000 $ 0.65 Granted 630,000 0.30 Vested ( 350,500 ) 0.65 Forfeited — — Outstanding at June 30, 2023 980,500 $ 0.43 Granted 1,360,000 0.28 Vested ( 615,500 ) 0.42 Forfeited — — Outstanding at June 30, 2024 1,725,000 $ 0.31 As of June 30, 2024 and 2023, there was approximately $ 250,221 and $ 170,404 of unamortized stock-based compensation expense related to outstanding RSUs. This expense is expected to be recognized over the remaining weighted-average vesting periods of 1.39 years. |